Trilobio
Private Company
Total funding raised: $4.2M
Overview
Trilobio is an early-stage biotech automation company offering a comprehensive 'self-driving lab' platform designed to overcome the cost, complexity, and inflexibility of traditional lab automation. Its core technology includes the Trilobot, a benchtop robotic arm with auto-calibration and tool-changing capabilities, and the Trilobio OS, a no-code software for protocol design and fleet management. By targeting the significant pain points of manual research and expensive, siloed automation systems, Trilobio aims to democratize advanced automation for academic labs, biotech startups, and research organizations, thereby increasing reproducibility, throughput, and data production.
Technology Platform
Integrated lab automation platform featuring the Trilobot (modular, auto-calibrating robotic arm with tool-changing) and Trilobio OS (no-code, biology-centric protocol design and execution software), supported by an open hardware/software ecosystem.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes against high-cost, integrated systems from large players like Thermo Fisher and Beckman Coulter, as well as other startups aiming to democratize lab automation. Differentiation lies in the combined no-code software, auto-calibration, tool-changing hardware, and open ecosystem at an affordable price point.